Yung Zip Chemical Ind. Co., Ltd. (TPEX: 4102)
Health Care · Pharmaceuticals · TW
NT$19.10
+0.53% today · -12.6% 1Y
Yung Zip Chemical Ind. Co., Ltd. (TPEX: 4102) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $25.42M and employs 184 people.
Over the last twelve months the share price has lost 12.6%, trading between 16.50 and 23.55.
Tweenvest scores Yung Zip Chemical Ind. Co., Ltd. across four factors: quality 72/100, value 77/100, growth 5/100. Its strongest factor is value.
4102 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $25.42M
- Revenue (TTM)
- $15.53M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- -0.08
- 52-week high
- NT$23.55
- 52-week low
- NT$16.50
- Avg volume (3M)
- —
- Shares outstanding
- 42.37M
- Employees
- 184
- Next earnings
- —
About Yung Zip Chemical Ind. Co., Ltd.
Yung Zip Chemical Ind. Co., Ltd. is a global provider specializing in the manufacture of essential pharmaceutical components. The company supplies active pharmaceutical ingredients (APIs), their intermediate precursors, and various specialty chemicals to markets around the world. Their diverse product portfolio includes a wide array of therapeutic agents addressing conditions such as hypertension, iron overload, inflammation, pain, fever, fungal infections, schizophrenia, blood clotting issues, genital herpes outbreaks, and sleep disorders (hypnotics and sedatives). In addition to these core offerings, Yung Zip also provides pharmaceutical excipients, such as sodium starch glycolate, and offers bespoke research, development, and manufacturing services. The company, established in 1978, is headquartered in Taichung, Taiwan.
- ISIN
- TW0004102009
- Founded
- 1978
- Listed since
- Dec 31, 2007
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,234.92 | +0.10% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.25 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.27 | -0.12% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.70 | -0.03% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.52 | -0.99% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.52 | -0.18% |
Figures last refreshed Aug 18, 2026.